REF:

C1317 (Multiple Cassette)

INTENDED PURPOSE:

NOVAtest® TORCH IgM Antibody Multiple Test is an immunochromatographic assay that use immuno-capture method for qualitative detection of toxoplasma, rubella virus, cytomegalovirus, HSV-1 and HSV-2 specific IgM antibodies from serum and plasma specimens of human. It’s used as an aid in the screen of the prenatal infection. This device is performed manually.

INTENDED USER:

Performance of the test is limited to laboratory professional use.

SUMMARY:

TORCH testing is a diagnostic panel designed to identify infections that can negatively impact fetal development during pregnancy. TORCH is an acronym representing Toxoplasmosis, Rubella, Cytomegalovirus, and Herpes Simplex. This comprehensive test assesses antibodies against these infectious agents, aiding in the identification of potential maternal-fetal transmission. Each pathogen tested has the potential to cause congenital abnormalities. This aspect underscores the significance of the TORCH test in prenatal care, enabling the early detection and management of infections that could pose serious risks to the developing fetus. Timely identification through TORCH testing facilitates appropriate medical interventions, contributing to improved maternal and neonatal outcomes.

Toxoplasma is a parasitic infection, particularly risky during pregnancy and for individuals with weakened immune systems. Rubella virus, causing German measles, poses a significant threat during pregnancy, potentially resulting in severe birth defects. Cytomegalovirus, a common virus, can lead to severe complications in newborns and individuals with weakened immune systems. Herpes Simplex Virus-1 (HSV-1) is responsible for oral herpes, causing cold sores and fever blisters on or around the mouth. Herpes Simplex Virus-2 (HSV-2) leads to genital herpes, with symptoms including painful sores in the genital and anal areas.